Livewire Ergogenics Upgraded to OTCID Beginning of the next Growth Phase

April 13, 2026

Livewire Ergogenics Upgraded to OTCID

Anaheim, CA, April 13, 2026 – Livewire Ergogenics Inc. (OTCID: LVVV) announces its recent upgrade from OTCPINK to OTCID, a move that signifies a strategic step forward in the OTC Market platform. This upgrade underscores the company’s commitment to growth and transparency, aiming to rebuild confidence among shareholders and attract new investors through enhanced disclosure standards.

“This upgrade marks the beginning of Livewire’s continued corporate evolution and the beginning of the next growth phase,” said CEO Bill Hodson. We have rebuilt our foundation, sharpened our focus, and positioned the Company to compete in some of the fastest-growing segments of the wellness and cannabinoid markets with our SOL VIDA functional wellness products. This upgrade to the OTCID Markets platform, for which more disclosure details will follow, reflects the Company’s renewed commitment to transparency, regulatory compliance, and shareholder value. Our new status enhances our market visibility, supports broker-dealer participation, improves trading liquidity, and broadens the potential investor base while positioning the Company for future market tier upgrades.”

Mr. Hodson continues: “As detailed in our filings, we have shifted from a capital-intensive, large-scale outdoor cannabis cultivation model to an asset-light, brand-driven strategy. Our revised business model focuses on developing high-margin, specialized functional wellness products that are less hampered by complex regulatory obstacles, reflecting a confident move toward sustainable growth and a positive outlook as we advance our botanical wellness initiatives.

By sourcing widely available, competitively priced, high-quality materials from long-standing, carefully selected and tested partners, we will be able to sell our products with significantly higher profit margins than if we used our own high-cost source materials. Livewire can now focus on what drives value: product innovation, brand development, and market expansion – all while operating with significantly improved revenue generation and profit margin potential.

At the center of this strategy is Livewire’s growing SOL VIDA™ line of cannabinoid- and hemp-derived specialty products, along with an expanding portfolio of functional wellness offerings, some curated from our partners. These products are distributed through:

Licensed wellness and cannabis distributors

Established dispensary and retail networks

Direct-to-consumer delivery channels

The Company’s own “Livewire Vida” online platform (going online asap)

Depending on product configuration and regulatory allowances, Livewire products are being introduced in California and Nationwide, positioning the Company to participate in a rapidly expanding national functional wellness movement. Our plans to expand product development and explore new partnerships are designed to inspire confidence and enthusiasm about Livewire’s growth trajectory.

Livewire is positioning itself at the intersection of wellness, lifestyle, and next-generation cannabinoid innovation.

Increase efficiency and profit margins

Expand product development

Explore new partnerships and acquisitions

Capture opportunities in the booming functional wellness market

Livewire will operate with lower overhead, be less handicapped by regulatory complexity, and focus strongly on premium-branded goods to accelerate revenue growth and profitability.

“After having spent many years in the cannabis cultivation market, we believe we are aligned with where consumer demand is going,” Hodson added. “Today’s market rewards functional wellness brands, quality, and smart execution — and that is exactly where Livewire is focused. As reported in our financial reports for the first three quarters of 2025, we have completed our business model transition and intend to finalize and report all remaining adjustments in our 2025 Annual Report, expected to be filed in March 2026.

About Livewire Ergogenics Inc.

Livewire Ergogenics Inc. develops and markets innovative functional Wellness Products that meet growing consumer demand for healthier, mindful lifestyle solutions and deliver meaningful results for its customers. Through its SOL VIDA™ and “Botanical Brilliance” wellness brands, the company offers a broad range of general wellness solutions, hemp-derived formulations, and select THC- and CBD-based specialty products where legally permitted. Livewire distributes its products through licensed partners, retail networks, and direct-to-consumer channels across the United States, depending on product configuration and regulatory guidelines. By expanding its presence in the fast-growing wellness sector, the Company aims to capture significant market opportunities to create long-term shareholder value in the rapidly expanding wellness economy while maintaining strict regulatory compliance and transparency.

DISTRIBUTORS AND DISPENSARIES
FOR SALES AND DISTRIBUTION INQUIRIES OF ESTRELLA RIVER FARMS PRODUCTS
PLEASE EMAIL INFO@LIVEWIREERGOGENICS.COM

For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com.
For the latest updates and news, we encourage you to follow LiveWire Ergogenics at livewireergogenics.com or go to www.stockwatchindex.com for non-material updates.

Forward-Looking Statements 

This release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. All forward-looking statements, predictions, and projections are inherently uncertain as they are based on current expectations and assumptions of the successful execution of plans or the Company’s general future performance. Readers are cautioned not to rely on these forward-looking statements, which are predictions and speak only as of the date hereof. Prospective investors should carefully review various risks and uncertainties inherent in this release, the Company’s Social Media postings, and matters outlined in the Company’s SEC/OTC filings. The Company’s results may differ materially from those indicated in the forward-looking statements.